Search details
1.
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study.
Ann Hematol
; 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38662205
2.
Activation of the TLR4/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A.
Oncol Lett
; 15(6): 9647-9654, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29928340
Results
1 -
2
de 2
1
Next >
>>